Delivery Order SPE2DB22D3401-SPE2DB25FT6JC
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 with a ceiling value of $5,904.08. This competitively awarded, non-set-aside delivery order carries a firm fixed price structure and is scheduled for completion by September 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 100s, with a ceiling value of $11,707.25. The delivery order represents a firm fixed price, competitive award with no set-aside designation and an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 tablets, with a ceiling value of $4,397.88. This non-competitive, firm fixed-price delivery order is set to be completed by September 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Terbinafine HCL 250 mg tablets (30-count packages) with a ceiling value of $4,107.11. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competitive procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30, with a ceiling value of $7,207.59. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by September 17, 2025. AmerisourceBergen's place of performance is located in Conshohocken, Pennsylvania, reflecting the company's headquarters location and...
- The Defense Logistics Agency awarded a delivery order valued at approximately $39,194 to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Terbinafine HCl 250 mg tablets in quantities of 100 units. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 27, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $8,633.30, represents a non-set-aside competitive award with an ultimate completion date of September 19, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for Terbinafine HCL 250 mg tablets (30-count) with a ceiling value of $1,015.23. This firm fixed-price delivery order, which is not set-aside, represents a routine pharmaceutical procurement supporting federal medical supply needs. The award was executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 units, with a ceiling value of $3,320.50. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion on August 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a typical transactional delivery...
- The Defense Logistics Agency awarded a $1,436.96 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Terbinafine HCL 250 mg tablets (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of July 22, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB25FT6JCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Terbinafine HCL 250 mg tablets (90-count units) with a ceiling value of $2,997.94. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract specifies an ultimate completion date of September 22, 2025, and performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal military and veteran healthcare systems. The company's substantial IDC vehicle with DLA enables it to supply a broad spectrum of pharmaceutical products and medical supplies to support military healthcare programs globally, including medications for various therapeutic domains. This specific terbinafine order represents a routine medical supply fulfillment typical of the company's extensive portfolio of competitively awarded federal contracts with the Defense Logistics Agency, supporting the medical supply chain requirements of the Department of Defense and affiliated healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 9/19/25 |